Compare · head to head
Labcorp vs Mistras
Labcorp ranks higher overall — 360 rank 40 vs 33.
Labcorp leads on Value (47 vs 35), Quality (57 vs 41) and Safety (53 vs 30). Mistras leads on Growth (72 vs 45) and Sentiment (54 vs 36).
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | USA | USA |
| Sector | Health Care | Business Services |
| Industry | Health Care Providers & Services | Professional Services |
| Size | X-Large | Medium |
| ISIN | US5049221055 | US60649T1079 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 40 | 33 |
| Value | 47 | 35 |
| Quality | 57 | 41 |
| Growth | 45 | 72 |
| Safety | 53 | 30 |
| Sentiment | 36 | 54 |
| Quality details | ||
| Profitability | 64 | 50 |
| Cash Truth | 50 | 33 |
Labcorp vs Quest DiagnosticsLabcorp vs SchrödingerLabcorp vs Adaptive BiotechnologiesLabcorp vs Spero TherapeuticsAdd a third stock →
Full analyses: Labcorp · Mistras
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100